Center for Financial Planning’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11	Closed	-$1.5K	–	735
2024 Q4	$1.5K	Buy	+11	New	+$1.5K	﹤0.01%	564